Targeting HER family receptors in breast cancer | slideum.com

share and download study presentations

Upload

Log In

Login

Register

Directory

Related presentations

T-DM1 - Research To Practice

Pertuzumab + Trastuzumab + Docetaxel

Rugo LBBC metastatic disease 10.2012

Anti HER2 mAbs

A Phase Ib/II Trial of Trastuzumab-DM1 (T

Responses to Subsequent Anti-HER2 Therapy After Treatment with Positive Metastatic Breast Cancer

New Targeted Agents Demonstrate Greater Efficacy and Tolerability

Targeting HER family receptors in breast cancer

Download Report

Transcript Targeting HER family receptors in breast cancer

Company
Nicosia Constantinou Palaiologou 16, Palouriotissa, 1040
+357 64-733-402
[email protected]

Links
About
Contact
Help / FAQ

Legal
Terms of Service
Privacy policy
Cookie policy
Disclaimer

slideum.com © 2026, Inc. All rights reserved.

Directory